Dose finding with a novel recombinant plasminogen activator (BM 06,022) in patients with acute myocardial infarction: Results of the German recombinant plasminogen activator study

This publication has 13 references indexed in Scilit:

• Improved thrombolysis in acute myocardial infarction with front-loaded administration of alteplase: Results of the rt-PA-APSAC patency study (TAPS)
  Journal of the American College of Cardiology, 1992
• Evaluation of thrombolytic and systemic effects of the novel recombinant plasminogen activator BM 06.022 compared with alteplase, anistreplase, streptokinase and urokinase in a canine model of coronary artery thrombosis
  Journal of the American College of Cardiology, 1992
• Pharmacokinetics of the novel recombinant plasminogen activator BM 06.022 in rats, dogs, and non-human primates
  Fibrinolysis, 1992
• Coronary recanalization rate after intravenous bolus of alteplase in acute myocardial infarction
  The American Journal of Cardiology, 1991
• Improved thrombolysis with a modified dose regimen of recombinant tissue-type plasminogen activator
  Journal of the American College of Cardiology, 1989
• Single-bolus injection of recombinant tissue-type plasminogen activator in acute myocardial infarction
  The American Journal of Cardiology, 1989
• Intravenous Recombinant Tissue Plasminogen Activator (rt-PA) and Urokinase in Acute Myocardial Infarction: Results of the German Activator Urokinase Study (GAUS)
  Journal of the American College of Cardiology, 1988
• Issues in designing sequential stopping rules for monitoring side effects in clinical trials
  Controlled Clinical Trials, 1987
• Thrombolysis in myocardial infarction (TIMI): Comparative studies of coronary reperfusion and systemic fibrinogenolysis with two forms of recombinant tissue-type plasminogen activator
  Journal of the American College of Cardiology, 1987
• The Thrombolysis in Myocardial Infarction (TIMI) Trial
  New England Journal of Medicine, 1985